Both Mounjaro and Wegovy are GLP-1 receptor agonists. So, GLP-1 is basically usually released after eating, sending a signal to your brain that you’re full up and delaying the e ...

Our writer thinks these two shares are well worth checking out for investors targeting a growing stream of passive income over the next few years.